Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

More oxazolidinone antimicrobial agents under study at P&U

Jan. 14, 1997

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

New compounds for heparin reversal disclosed by University of Michigan

Jan. 14, 1997

NO donors claimed by Searle for cardiovascular applications

Jan. 13, 1997

Allergan claims retinoid-like compounds

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

New topoisomerase I inhibitors synthesized at Rutgers

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...